The Subcellular Targets of Mercaptoborate (BSH), a Carrier of 10B for Neutron Capture Therapy (BNCT) of Brain Tumors

Physiological Research

Volumn 52, Issue 5, 2003, Pages 629-635

  Mares V ^a,b,d   Krajci D ^c   Lisa V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b J E PURKINJE UNIVERSITY   (Czech Republic)

^c KUWAIT UNIVERSITY   (Kuwait)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Borocaptate (BSH); Brain tumors; Mitochondria; Neutron Capture Therapy (NCT); Nucleus

Indexed keywords

BORINIC ACID DERIVATIVE; BORON 10; MERCAPTOBORATE; SODIUM MERCAPTOBORATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CELL ACTIVATION; CELL GROWTH; CELL HETEROGENEITY; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL TRANSFORMATION; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON MICROSCOPY; GLIA CELL; LYSOSOME; MEMBRANE VESICLE; MICROSCOPIC ANATOMY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEOLUS; OXIDATIVE STRESS; PINOCYTOSIS; RAT; THERMAL ANALYSIS;

ANIMALS; BOROHYDRIDES; BORON; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CELL COUNT; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; ISOTOPES; MICROSCOPY, ELECTRON; MICROSCOPY, PHASE-CONTRAST; MITOCHONDRIA; RATS; SULFHYDRYL COMPOUNDS;

EID: 0242322739     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BARTH RF, SOLOWAY AH, GOODMAN JH, GAHBAUER RA, GUPTA N, BLUE TE, YANG W, JARKS W: Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44: 433-451, 1999.
2. BUCHAR E, BEDNÁŘOVÁ S, GRUNER B, ŠTROUF O, JANKŮ I: Dose-dependent disposition kinetics and tissue accumulation of boron after intravenous injections of purified mercaptoundecahydrododecaborate in rabbits. Cancer Chemother Pharmacol 29: 450-454, 1992.
3. COUSIN B, CINTI S, MORRONI M, RAIMBAULT S, RICQUIER D, PENICAUD L, CASTEILLA L: Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 103: 931-942, 1992
4. DEAMS WT, WISSE E: Shape and attachment of the cristae mitochondriales in mouse hepatic cell mitochondria. J Ultratstruct Res 16:123-140, 1966.
5. DRAHOTA Z, MAREŠ V, RAUCHOVÁ H, ŠAF P, KALOUS M: Inhibition of mitochondrial ATPase by dicarbopolyborate, a new enzyme inhibitor. J Bioenerget Biomembr 26: 583-586, 1994.
6. DRAHOTA Z, RAUCHOVÁ H, SEDLÁK V, KOĆÍ J, ČERVINKOVÁ Z: The effect of triiodothyronine on changes of membrane fluidity in regenerating rat liver. Physiol Res 48: 167-170, 1999.
7. FREY TG, MANNELLA CA: The internal structure of mitochondria. Trends in Biochem Sci 25: 319-324, 2000.
8. GAVIN PR, KRAFT SL, DEHAAN SE, SWARTZ CD, GRIEBENOW ML: Large animal normal tissue tolerance with boron neutron capture. Int. J. Radiation Oncology Biol Phys 28: 1099-1106, 1994.
9. GIBSON CR, STAUBUS AE, BARTH RF, YANG W, KLEINHOLZ NM, JONES RB, GREE-CHURCH K, TJARKS W, SOLOWAY AH: Boron neutron capture therapy of brain tumors: Investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectroscopy. Drug Metabolism and Disposition 29: 1588-1598, 2001.
10. GILKERSON RW, MARGINEANTU DH, CAPALDI RA, SELKER JM: Mitochondrial DNA depletion causes morphological changes in the mitochondrial reticulum of cultured human cells. FEBS Lett 474: 1-4, 2000.
11. 11SH in patients with glioblastoma. Cancer Res 54: 6318-20, 1994a.
12. 11SH. J Neurosurg 81: 741-744, 1994b.
13. HATANAKA H, SWEET WH: Slow neutron capture therapy for malignant tumors. Its history and recent development. In: Advances of Biomedical Dosimetry. International Atomic Energy Agency Press, Wien, 1975, pp 146-178.
14. HORN V, BUCHAR E, JANKŮ I: Kidney function changes in rats after a single-dose administration of borocaptate sodium. Physiol Res 46: 279-283, 1997.
15. JANKŮ I, BUCHAR E, JIŘIČKA Z: Nephrotoxicity of borocaptate after short-term administration on rabbits. Toxicology 79: 99-108, 1993.
16. KASAPOVIC J, PAJOVIC SB, PEJIC S, MARTINOVIC JV: Effects of estradiol benzoate and progesterone on superoxide dismutase activity in the thymus of rats. Physiol Res 50: 97-103, 2001.
17. KLIEGEL W: Bor in Biologie und Pharmazie. Springer-Verlag, Berlin, 1980.
18. KOUDINOVA J, ELHANATI G, SALOMON Y, BENDEL P: Uptake of BSH in M2R melanoma cells monitored by NMR spectroscopy. In: Frontiers in Neutron Capture Therapy. MF HAWTHORNE, K SHELLY, R WIERSMA (eds), Plenum Press, New York, 2000, p. 289.
19. KUCHARSKÁ J, BRAUNOVÁ Z, ULIČNÁ O, ZLATOŠ L, GVOZDJAKOVÁ A: Deficit of coenzym Q in heart and liver mitochondria of rats with streptozotocin-induced diabetes. Physiol Res 49: 411-418, 2000.
20. LAHANN TR, HEMATILAKE G, LARSEN J, DANIEL D: Cardiovascular toxicity associated with a single dose administration of the boron delivery drug borocaptate sodium. In: Advances in Neutron Capture Therapy, vol. II. J. CRAWFORD, AND R. WEINRICH (eds), Elsevier, 1997a, pp. 192-196.
21. LAHANN TR, SPIEGEL K, SPALL R, GRIEBENOW M: Evaluation of the toxicity associated with repeat administration of the boron delivery drug borocaptate sodium. In: Advances in Neutron Capture Therapy, vol. II, J CRAWFORD, R WEINRICH (eds), Elsevier, 1997 b, pp. 185-191.
22. LOTKOVA H, RAUCHOVA H, DRAHOTA Z: Activation of mitochondrial glycerophosphate cytochrome c reductase in regenerating rat liver by triiodothyronine. Physiol Res 50: 333-336, 2001.
23. MAREŠ V, M. BAUDYŠOVÁ, J. KVÍTEK, V. HNATOWICZ, J. ČERVENÁ, J. VACÍK, J.FOLBERGROVÁ: Accumulation of boron-10 in cell cultures exposed to mercaptododecaborate used for the neutron capture therapy. J Pharmacol Exp Therapeutics 262: 818-822, 1992.
24. MAREŠ V, LISÁ V, DRAHOTA Z, BAČÁKOVÁ L, ŠPANOVÁ A, KVÍTEK J, HNATOWICZ V, BURIAN J: Toxicity, uptake and retention of sodium mercaptoborate (BSH) in glial and glioma cells in culture. In: Advances in Neutron Capture Therapy, vol. II. J CRAWFORD, R WEINRICH (eds), Elsevier, Amsterdam, 1997 pp. 210-215.
25. NAKADA K, INOUE K, CHEN CS, NONAKA I, GOTO Y, OGURA A, HAYASHI JI.: Correlation of functional and ultrastructural abnormalities of mitochondria in mouse heart carrying a pathogenic mutant mtDNA with a 4696-bp deletion. Biochem Biophys Res Commun 288: 901-907, 2001.
26. 11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy. J Neurooncol 33:131-139, 1977.
27. PERKINS GA, SONG JY, TARSA L, DEERINCK TJ, ELLISMAN MH, FREY TG.: Electron tomography of mitochondria from brown adipocytes reveals crista junctions. J Bioenerg Biomembr 30: 431-442, 1998.
28. RADOVANOVIC J, TODOROVIC V, BORICIC I, JANKOVIC-HLADNI M, KORAC A: Comparative ultrastructural studies on mitochondrial pathology in the liver of AIDS patients: clusters of mitochondria, protuberances, " minimitochondria," vacuoles, and virus-like particles. Ultrastruct Pathol 23: 19-24, 1999.
29. SHEPARD TH, MUFFLEY LA, SMITH LT: Ultrastructural study of mitochondria and their cristae in embryonic rats and primate (N. nemistrina). Anat Rec 252: 383-392, 1998.
30. STRAGLIOTTO G, FANKHAUSER H: Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors. Neurosurgery 36: 285-293, 1995.
31. SWEET WH, MESSER JR, HATANAKA H: Supplementary pharmacological study between 1972 and 1977 on purified mercaptoundecahydrododecaborate. In: Boron Neutron Capture Therapy of Tumors. H. HATANAKA (ed), Nishimura Co., Ltd., Niigata, 1986, pp. 59-76.
32. YOSHINAGA-HIRABAYASHI T, YONEDA Y.: Expression of SCC in ovarian granulosa cells and cultured cells induced rapid structural changes in mitochondria. Ital J Anat Embryol 106 (Suppl 1): 51-57, 2001.